(R)-1-(N-benzyloxycarbonylamino)ethylphosphinic acid
95%
- Product Code: 37371
CAS:
115115-40-7
| Molecular Weight: | 243.196221 g./mol | Molecular Formula: | C₁₀H₁₄NO₄P |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various pharmacologically active molecules, particularly those targeting neurological disorders. Its structure is often incorporated into the design of enzyme inhibitors, especially for enzymes involved in neurotransmitter regulation. Additionally, it is used in the preparation of peptide mimetics, which are important in developing therapeutic agents with enhanced stability and bioavailability. Researchers also employ this compound in studies focused on understanding the mechanisms of phosphinic acid derivatives in biological systems, aiding in the discovery of novel treatments for diseases such as epilepsy and Alzheimer's.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | $282.35 |
+
-
|
| 1.000 | 10-20 days | $698.26 |
+
-
|
(R)-1-(N-benzyloxycarbonylamino)ethylphosphinic acid
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various pharmacologically active molecules, particularly those targeting neurological disorders. Its structure is often incorporated into the design of enzyme inhibitors, especially for enzymes involved in neurotransmitter regulation. Additionally, it is used in the preparation of peptide mimetics, which are important in developing therapeutic agents with enhanced stability and bioavailability. Researchers also employ this compound in studies focused on understanding the mechanisms of phosphinic acid derivatives in biological systems, aiding in the discovery of novel treatments for diseases such as epilepsy and Alzheimer's.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :